AB
AEON BiopharmaClinical-stage biopharmaceutical company developing ABP-450 (prabotulinumtoxinA), a biosimilar to Botox, for therapeutic indications like cervical dystonia and chronic migraine.
1 Pulse story
DF
Drug FarmDrug Farm is a biotech developing AI-designed small-molecule drugs for rare and immune-inflammatory diseases, led by DF-003, a Phase 3 ALPK1 inhibitor for ROSAH syndrome.
2 Pulse stories
Total Raised
$138M
AEON BiopharmaDrug Farm
Last ValuationNot disclosed
Biotech
Sector
Biotech
2013
Founded
2015
Irvine, California
HQ
Shanghai, China / New York, NY
Public (AEON)
Status
Private
AEON Biopharma investors
No investors on record.
Drug Farm investors
Shanghai Pudong Leading Area Investment CenterShanghai Puxing Collaborative Private Equity FundDetong CapitalWuXi AppTecBioVeda China FundYD CapitalBetta CapitalWedo Venture Management
Data from Value Add Pulse coverage and company research — see the full threads for AEON Biopharma and Drug Farm.